Form D · Other Health Care
METABOLON, INC
Durham, NC · CIK 0001223710
Offering snapshot reported Jan 10, 2025 · SEC filing
- Reported sold
- $7.5M Offering amount: $16.4M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2025 | Initial | $7,500,000 | No comparison | 11 | SEC filing |
| Nov 10, 2022 | Initial | $10,043,517 | No comparison | 11 | SEC filing |
| Sep 11, 2020 | Initial | $21,766,390 | No comparison | 11 | SEC filing |
| Mar 30, 2020 | Amendment | $7,750,000 | $6,250,000vs Aug 27, 2019 | 11 | SEC filing |
| Aug 27, 2019 | Initial | $1,500,000 | No comparison | 8 | SEC filing |
| Aug 29, 2018 | Initial | $7,300,003 | No comparison | 9 | SEC filing |
| Dec 15, 2016 | Amendment | $30,000,000 | $15,000,000vs Aug 25, 2016 | 2 | SEC filing |
| Aug 25, 2016 | Initial | $15,000,000 | No comparison | 2 | SEC filing |
| Mar 12, 2015 | Initial | $5,049,994 | No comparison | 4 | SEC filing |
| Dec 30, 2013 | Initial | $14,999,980 | No comparison | 15 | SEC filing |
| Sep 7, 2011 | Initial | $13,154,991 | No comparison | 12 | SEC filing |
| Nov 5, 2009 | Initial | $6,076,362 | No comparison | 5 | SEC filing |
| Jul 1, 2009 | Amendment | $6,273,642 | $1,003,065vs May 11, 2009 | 7 | SEC filing |
| May 11, 2009 | Initial | $5,270,577 | No comparison | Not reported | SEC filing |
| Mar 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 30, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-534676
Source: Form D, filed Jan 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R. Scott Barry | Director |
| Scott Barry | Director |
| Robert Cascella | Director |
| C. Thomas Caskey | Director |
| C Thomas Caskey | Director |
| B. Jefferson Clark | Director |
| Jefferson B. Clark | Director |
| Santo J. Costa | Director |
| Edward L. Erickson | Director |
| Edward L. Erikson | Director |
| Guy Fish | Director |
| John Fletcher | Director |
| R. John Fletcher | Director |
| Stephen Furlong | Executive |
| Gerald M. Haines Ii | Executive |
| Rohan F. Hastie | Director, Executive |
| Rudy Howard | Director |
| Christopher Kersey | Director |
| John Kurtzweil | Executive |
| Jan Lundberg | Director |
| S. Todd Lynch | Executive |
| Carol A. Marino | Director |
| John Oxaal | Director |
| David Pierson | Director |
| John A. Ryals | Director |
| Todd Schermerhorn | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
617 Davis Drive Suite 100
Durham, NC, 27560
Durham, NC, 27560